Clinical Trial Update: 6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks

View source ↗

Summary

A clinical trial update from Paris describes the TOCOPROM study comparing nifedipine versus placebo for tocolysis in preterm prelabor rupture of membranes at 22…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prelabor Rupture of Membranes
• Preterm Birth

Drugs mentioned

• Nifedipine (nifedipine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Children Born to Mothers Enrolled in the TOCOPROM Trial | Status: RECRUITING